Loss of mitochondrial complex I activity potentiates dopamine neuron death induced by microtubule dysfunction in a Parkinson’s disease model
Open accessThe DOI matches its Crossref record; 58 of the 59 references it cites were found in a registry or an index.
Abstract
Mitochondrial complex I dysfunction is regarded as underlying dopamine neuron death in Parkinson’s disease models. However, inactivation of the Ndufs4 gene, which compromises complex I activity, does not affect the survival of dopamine neurons in culture or in the substantia nigra pars compacta of 5-wk-old mice. Treatment with piericidin A, a complex I inhibitor, does not induce selective dopamine neuron death in either Ndufs4+/+ or Ndufs4−/− mesencephalic cultures. In contrast, rotenone, another complex I inhibitor, causes selective toxicity to dopamine neurons, and Ndufs4 inactivation potentiates this toxicity. We identify microtubule depolymerization and the accumulation of cytosolic dopamine and reactive oxygen species as alternative mechanisms underlying rotenone-induced dopamine neuron death. Enhanced rotenone toxicity to dopamine neurons from Ndufs4 knockout mice may involve enhanced dopamine synthesis caused by the accumulation of nicotinamide adenine dinucleotide reduced. Our results suggest that the combination of disrupting microtubule dynamics and inhibiting complex I, either by mutations or exposure to toxicants, may be a risk factor for Parkinson’s disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures









Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“For example, the CI inhibitor rotenone destabilizes microtubules, 40,41 and the CII inhibitor α-TOS as well as the complex III inhibitor antimycin act as BH3 mimetics.42,43”
From Ubiquinone-binding site mutagenesis reveals the role of mitochondrial complex II in cell death initiation (2015) · cites this paper as [40]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dauer, W., & Przedborski, S. (2003) · Neuron · doi:10.1016/s0896-6273(03)00568-3 · Cited by 5,469
Chronic Parkinsonism in Humans Due to a Product of Meperidine-Analog Synthesis
Langston, J. W., Ballard, P., Tetrud, J. W., & Irwin, I. (1983) · Science · doi:10.1126/science.6823561 · Cited by 4,914
Chronic systemic pesticide exposure reproduces features of Parkinson's disease
Betarbet, R., Sherer, T. B., MacKenzie, G., Garcia-Osuna, M., Panov, A. V., & Greenamyre, J. T. (2000) · Nature Neuroscience · doi:10.1038/81834 · Cited by 3,683
MITOCHONDRIAL COMPLEX I DEFICIENCY IN PARKINSON'S DISEASE
Schapira, A. H. V., Cooper, J. M., Dexter, D., Jenner, P., Clark, J. B., & Marsden, C. D. (1989) · The Lancet · doi:10.1016/s0140-6736(89)92366-0 · Cited by 1,756
Enforced dimerization of BAX results in its translocation, mitochondrial dysfunction and apoptosis
Gross, A., Jockel, J., Wei, M. C., & Korsmeyer, S. J. (1998) · The EMBO Journal · doi:10.1093/emboj/17.14.3878 · Cited by 1,086
Mechanism of Toxicity in Rotenone Models of Parkinson's Disease
Sherer, T. B., Betarbet, R., Testa, C. M., Seo, B. B., Richardson, J. R., Kim, J. H., Miller, G. W., Yagi, T., Matsuno-Yagi, A., & Greenamyre, J. T. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-34-10756.2003 · Cited by 1,072
Abnormalities of the electron transport chain in idiopathic parkinson's disease
Parker, W. D., Boyson, S. J., & Parks, J. K. (1989) · Annals of Neurology · doi:10.1002/ana.410260606 · Cited by 1,063
Expanding insights of mitochondrial dysfunction in Parkinson's disease
Abou-Sleiman, P. M., Muqit, M. M. K., & Wood, N. W. (2006) · Nature Reviews Neuroscience · doi:10.1038/nrn1868 · Cited by 869 · cited 1×
“Inhibition of mitochondrial complex I has long been one of the leading theories (Abou-Sleiman et al., 2006).”
Keeney, P. M., Xie, J., Capaldi, R. A., & Bennett, J. P. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.0984-06.2006 · Cited by 747
Deficiencies in Complex I subunits of the respiratory chain in Parkinson's disease
Mizuno, Y., Ohta, S., Tanaka, M., Takamiya, S., Suzuki, K., Sato, T., Oya, H., Ozawa, T., & Kagawa, Y. (1989) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(89)91141-8 · Cited by 739
Cited by
Exner, N., Lutz, A. K., Haass, C., & Winklhofer, K. F. (2012) · The EMBO Journal · doi:10.1038/emboj.2012.170 · Cited by 642
Parkinson's disease: Mechanisms, translational models and management strategies
Raza, C., Anjum, R., & Shakeel, N. U. A. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.03.057 · Cited by 603
Pathogenesis of Parkinson disease—the gut–brain axis and environmental factors
Klingelhoefer, L., & Reichmann, H. (2015) · Nature Reviews Neurology · doi:10.1038/nrneurol.2015.197 · Cited by 598
Neurotoxin-based models of Parkinson's disease
Bové, J., & Perier, C. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2011.10.057 · Cited by 506
Leigh syndrome: One disorder, more than 75 monogenic causes
Lake, N. J., Compton, A. G., Rahman, S., & Thorburn, D. R. (2016) · Annals of Neurology · doi:10.1002/ana.24551 · Cited by 497
Axon degeneration in Parkinson's disease
Burke, R. E., & O'Malley, K. (2013) · Experimental Neurology · doi:10.1016/j.expneurol.2012.01.011 · Cited by 493
Pan-Montojo, F., Schwarz, M., Winkler, C., Arnhold, M., O'Sullivan, G. A., Pal, A., Said, J., Marsico, G., Verbavatz, J.-M., Rodrigo-Angulo, M., et al. (2012) · Scientific Reports · doi:10.1038/srep00898 · Cited by 405
The Role of Mitochondrially Derived ATP in Synaptic Vesicle Recycling
Pathak, D., Shields, L. Y., Mendelsohn, B. A., Haddad, D., Lin, W., Gerencser, A. A., Kim, H., Brand, M. D., Edwards, R. H., & Nakamura, K. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.656405 · Cited by 311
Mechanisms and roles of mitophagy in neurodegenerative diseases
Wang, Y., Liu, N., & Lu, B. (2019) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.13140 · Cited by 213
Bordt, E. A., & Polster, B. M. (2014) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2014.07.033 · Cited by 202
“It is also generally not appreciated that rotenone, in contrast to the complex I inhibitor piericidin A [94], impairs microtubule assembly in the low nanomolar range [94–97].”
Cellular and Molecular Basis of Neurodegeneration in Parkinson Disease
Zeng, X.-S., Geng, W.-S., Jia, J.-J., Chen, L., & Zhang, P.-P. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00109 · Cited by 193
Modelling of Parkinson's disease in mice
Chesselet, M.-F., & Richter, F. (2011) · The Lancet Neurology · doi:10.1016/s1474-4422(11)70227-7 · Cited by 192
Leigh Syndrome: Neuropathology and Pathogenesis
Lake, N. J., Bird, M. J., Isohanni, P., & Paetau, A. (2015) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0000000000000195 · Cited by 172
AIF, reactive oxygen species, and neurodegeneration: A “complex” problem
Polster, B. M. (2012) · Neurochemistry International · doi:10.1016/j.neuint.2012.12.002 · Cited by 168
Rotenone-Induced Model of Parkinson’s Disease: Beyond Mitochondrial Complex I Inhibition
Ibarra-Gutiérrez, M. T., Serrano-García, N., & Orozco-Ibarra, M. (2023) · Molecular Neurobiology · doi:10.1007/s12035-022-03193-8 · Cited by 165
Lee, J. E., Park, J. H., Shin, I. C., & Koh, H. C. (2012) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2012.06.005 · Cited by 165
Lin, T.-K., Chen, S.-D., Chuang, Y.-C., Lin, H.-Y., Huang, C.-R., Chuang, J.-H., Wang, P.-W., Huang, S.-T., Tiao, M.-M., Chen, J.-B., et al. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms15011625 · Cited by 162
Haddad, D., & Nakamura, K. (2015) · FEBS Letters · doi:10.1016/j.febslet.2015.10.021 · Cited by 160
Energy Failure: Does It Contribute to Neurodegeneration?
Pathak, D., Berthet, A., & Nakamura, K. (2013) · Annals of Neurology · doi:10.1002/ana.24014 · Cited by 159
Cartelli, D., Casagrande, F., Busceti, C. L., Bucci, D., Molinaro, G., Traficante, A., Passarella, D., Giavini, E., Pezzoli, G., Battaglia, G., et al. (2013) · Scientific Reports · doi:10.1038/srep01837 · Cited by 129
Van Laar, V. S., & Berman, S. B. (2013) · Neurobiology of Disease · doi:10.1016/j.nbd.2012.05.015 · Cited by 131
Won, J.-H., Park, S., Hong, S., Son, S., & Yu, J.-W. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.667063 · Cited by 142
Targeting NAD+ Metabolism as Interventions for Mitochondrial Disease
Lee, C. F., Caudal, A., Abell, L., Gowda, G. A. N., & Tian, R. (2019) · Scientific Reports · doi:10.1038/s41598-019-39419-4 · Cited by 134
Pearson, B. L., Simon, J. M., McCoy, E. S., Salazar, G., Fragola, G., & Zylka, M. J. (2016) · Nature Communications · doi:10.1038/ncomms11173 · Cited by 127
LaMoia, T. E., Butrico, G. M., Kalpage, H. A., Goedeke, L., Hubbard, B. T., Vatner, D. F., Gaspar, R. C., Zhang, X., Cline, G. W., Nakahara, K., et al. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2122287119 · Cited by 113
Zhu, J. H., Gusdon, A. M., Cimen, H., Van Houten, B., Koc, E., & Chu, C. T. (2012) · Cell Death & Disease · doi:10.1038/cddis.2012.46 · Cited by 108
Helley, M., Pinnell, J. R., Sportelli, C., & Tieu, K. (2017) · Frontiers in Genetics · doi:10.3389/fgene.2017.00177 · Cited by 110
Parkin mutations reduce the complexity of neuronal processes in iPSC-derived human neurons
Ren, Y., Jiang, H., Hu, Z., Fan, K., Wang, J., Janoschka, S., Wang, X., Ge, S., & Feng, J. (2015) · Stem Cells · doi:10.1002/stem.1854 · Cited by 109
Microtubule-stabilizing agents as potential therapeutics for neurodegenerative disease
Brunden, K. R., Trojanowski, J. Q., Smith, A. B., Lee, V. M.-Y., & Ballatore, C. (2014) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2013.12.046 · Cited by 94
Photophysical Mechanisms of Photobiomodulation Therapy as Precision Medicine
Liebert, A. D., Capon, W., Pang, V., Vila, D., Bicknell, B. T., McLachlan, C. S., & Kiat, H. (2023) · Biomedicines · doi:10.3390/biomedicines11020237 · Cited by 105
Rotenone induces neuronal death by microglial phagocytosis of neurons
Emmrich, J. V., Hornik, T. C., Neher, J. J., & Brown, G. C. (2013) · The FEBS Journal · doi:10.1111/febs.12401 · Cited by 92
Pinho, B. R., Santos, M. M., Fonseca‐Silva, A., Valentão, P., Andrade, P. B., & Oliveira, J. M. A. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12186 · Cited by 100
Moretto, A., & Colosio, C. (2012) · Toxicology · doi:10.1016/j.tox.2012.11.021 · Cited by 97
Is Reliance on Mitochondrial Respiration a “Chink in the Armor” of Therapy-Resistant Cancer?
Wolf, D. A. (2014) · Cancer Cell · doi:10.1016/j.ccell.2014.10.001 · Cited by 85
Anticancer Drugs Targeting the Mitochondrial Electron Transport Chain
Rohlena, J., Dong, L.-F., Ralph, S. J., & Neuzil, J. (2011) · Antioxidants & Redox Signaling · doi:10.1089/ars.2011.3990 · Cited by 91
Cha, S. J., & Kim, K. (2022) · Antioxidants · doi:10.3390/antiox11020195 · Cited by 90
Ki, Y.-W., Lee, J. E., Park, J. H., Shin, I. C., & Koh, H. C. (2012) · Toxicology Letters · doi:10.1016/j.toxlet.2012.02.022 · Cited by 90
Rodríguez‐Rocha, H., García‐García, A., Pickett, C. S., Li, S., Jones, J., Chen, H., Webb, B., Choi, J. H., Zhou, Y., Zimmerman, M. C., et al. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.04.021 · Cited by 86
Sterky, F. H., Hoffman, A. F., Milenkovic, D., Bao, B., Paganelli, A., Edgar, D., Wibom, R., Lupica, C. R., Olson, L., & Larsson, N.-G. (2012) · Human Molecular Genetics · doi:10.1093/hmg/ddr537 · Cited by 77
Flex, E., Niceta, M., Cecchetti, S., Thiffault, I., Au, M., Capuano, A., Piermarini, E., Ivanova, A., Francis, J. W., Chillemi, G., et al. (2016) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2016.08.003 · Cited by 84
Calcium, Bioenergetics, and Parkinson’s Disease
Zampese, E., & Surmeier, D. J. (2020) · Cells · doi:10.3390/cells9092045 · Cited by 79
Complex I deficiencies in neurological disorders
Papa, S., & Rasmo, D. D. (2012) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2012.11.005 · Cited by 79
Choi, S. E., Park, Y. S., & Koh, H. C. (2018) · Environmental Toxicology · doi:10.1002/tox.22552 · Cited by 78
Lin, T., Cheng, C.-H., Chen, S., Liou, C., Huang, C., & Chuang, Y. (2012) · International Journal of Molecular Sciences · doi:10.3390/ijms13078722 · Cited by 75
Lieberman, O. J., Choi, S. J., Kanter, E., Saverchenko, A., Frier, M. D., Fiore, G. M., Wu, M., Kondapalli, J., Zampese, E., Surmeier, D. J., et al. (2017) · eneuro · doi:10.1523/eneuro.0167-17.2017 · Cited by 69
A Brief Review on the Neuroprotective Mechanisms of Vitexin
Lima, L. K. F., Pereira, S. K. S., Sousa, R. D. S., Santos, F. P. D. S., Nascimento, A. D. S., Feitosa, C. M., Figuerêdo, J. D. S., Cavalcante, A. D. N., Araújo, E. C. D. C., & Rai, M. (2018) · BioMed Research International · doi:10.1155/2018/4785089 · Cited by 70
Lee, J. E., Lim, M. S., Park, J. H., Park, C., & Koh, H. C. (2014) · NeuroToxicology · doi:10.1016/j.neuro.2014.04.001 · Cited by 68
Stykel, M. G., Humphries, K. M., Kirby, M. P., Czaniecki, C., Wang, T., Ryan, T. L., Bamm, V. V., & Ryan, S. D. (2018) · The FASEB Journal · doi:10.1096/fj.201700759rr · Cited by 68
Kluckova, K., Sticha, M., Cerny, J., Mracek, T., Dong, L., Drahota, Z., Gottlieb, E., Neuzil, J., & Rohlena, J. (2015) · Cell Death & Disease · doi:10.1038/cddis.2015.110 · Cited by 66
Krishna, G., & ., M. (2014) · Neurochemical Research · doi:10.1007/s11064-014-1323-1 · Cited by 66
Biosignatures for Parkinson’s Disease and Atypical Parkinsonian Disorders Patients
Potashkin, J. A., Santiago, J. A., Ravina, B. M., Watts, A., & Leontovich, A. A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0043595 · Cited by 64
The unique chemistry and biology of the piericidins
Zhou, X., & Fenical, W. (2016) · The Journal of Antibiotics · doi:10.1038/ja.2016.71 · Cited by 64
Palorini, R., Simonetto, T., Cirulli, C., & Chiaradonna, F. (2013) · International Journal of Cell Biology · doi:10.1155/2013/243876 · Cited by 64
Andruska, K. M., & Racette, B. A. (2015) · Current Epidemiology Reports · doi:10.1007/s40471-015-0040-x · Cited by 63
Valsecchi, F., Grefte, S., Roestenberg, P., Joosten-Wagenaars, J., Smeitink, J. A. M., Willems, P. H. G. M., & Koopman, W. J. H. (2012) · Mitochondrion · doi:10.1016/j.mito.2012.12.001 · Cited by 62
Antidepressant and Antioxidative Effect of Ibuprofen in the Rotenone Model of Parkinson’s Disease
Zaminelli, T., Gradowski, R. W., Bassani, T. B., Barbiero, J. K., Santiago, R. M., Ferreira, D. M., Baggio, C. H., & Vital, M. A. B. F. (2014) · Neurotoxicity Research · doi:10.1007/s12640-014-9467-y · Cited by 61
Rotenone-induced apoptosis and role of calcium: a study on Neuro-2a cells
Swarnkar, S., Goswami, P., Kamat, P. K., Gupta, S., Patro, I. K., Singh, S., & Nath, C. (2012) · Archives of Toxicology · doi:10.1007/s00204-012-0853-z · Cited by 60
Cartelli, D., Goldwurm, S., Casagrande, F., Pezzoli, G., & Cappelletti, G. (2012) · PLoS ONE · doi:10.1371/journal.pone.0037467 · Cited by 60
Mitochondrial dysfunction as a trigger of programmed axon death
Merlini, E., Coleman, M. P., & Loreto, A. (2021) · Trends in Neurosciences · doi:10.1016/j.tins.2021.10.014 · Cited by 59
Zhang, Q., Chen, S., Yu, S., Qin, J., Zhang, J., Cheng, Q., Ke, K., & Ding, F. (2016) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.04.025 · Cited by 59
The cytoskeletal arrangements necessary to neurogenesis
Compagnucci, C., Piemonte, F., Sferra, A., Piermarini, E., & Bertini, E. (2016) · Oncotarget · doi:10.18632/oncotarget.6838 · Cited by 57
Rotenone neurotoxicity: Relevance to Parkinson's disease
Lawana, V., & Cannon, J. R. (2020) · Advances in neurotoxicology · doi:10.1016/bs.ant.2019.11.004 · Cited by 57
Cellular and animal models for mitochondrial complex I deficiency: A focus on the NDUFS4 subunit
Breuer, M. E., Willems, P. H. G. M., Smeitink, J. A. M., Koopman, W. J. H., & Nooteboom, M. (2013) · IUBMB Life · doi:10.1002/iub.1127 · Cited by 56
de Haan, L. R., Reiniers, M. J., Reeskamp, L. F., Belkouz, A., Ao, L., Cheng, S., Ding, B., van Golen, R. F., & Heger, M. (2022) · Antioxidants · doi:10.3390/antiox11081424 · Cited by 55
Piroli, G. G., Manuel, A. M., Clapper, A. C., Walla, M. D., Baatz, J. E., Palmiter, R. D., Quintana, A., & Frizzell, N. (2016) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m115.051516 · Cited by 47
Self-citationAdjobo-Hermans, M. J. W., de Haas, R., Willems, P. H. G. M., Wojtala, A., Vries, S. E. V. E., Wagenaars, J. A. L., van den Brand, M. A. M., Rodenburg, R. J., Smeitink, J. A. M., Nijtmans, L. G. J., et al. (2020) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2020.148213 · Cited by 54
Choi, W., Kim, H.-W., Tronche, F., Palmiter, R. D., Storm, D. R., & Xia, Z. (2017) · Scientific Reports · doi:10.1038/srep44989 · Cited by 52
Self-citationNisar, R., Hanson, P. S., He, L., Taylor, R. W., Blain, P. G., & Morris, C. M. (2015) · Archives of Toxicology · doi:10.1007/s00204-015-1453-5 · Cited by 47
Subrahmanian, N., & LaVoie, M. J. (2021) · Brain Research · doi:10.1016/j.brainres.2021.147434 · Cited by 51
Quantitative neuropathology associated with chronic manganese exposure in South African mine workers
Gonzalez‐Cuyar, L. F., Nelson, G., Criswell, S. R., Ho, P., Lonzanida, J. A., Checkoway, H., Seixas, N. S., Gelman, B. B., Evanoff, B., Murray, J., et al. (2014) · NeuroToxicology · doi:10.1016/j.neuro.2013.12.008 · Cited by 51
Cabeza-Arvelaiz, Y., & Schiestl, R. H. (2012) · PLoS ONE · doi:10.1371/journal.pone.0044700 · Cited by 48
Karthivashan, G., Ganesan, P., Park, S., Lee, H., & Choi, D. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2019.119704 · Cited by 48
Neurotoxicité des pesticides: Quel impact sur les maladies neurodégénératives ?
Thany, S. H., Reynier, P., & Lenaers, G. (2013) · médecine/sciences · doi:10.1051/medsci/2013293013 · Cited by 48
Samal, J., Rebelo, A. L., & Pandit, A. S. (2019) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2019.01.012 · Cited by 43
Pyrroloquinoline quinone-conferred neuroprotection in rotenone models of Parkinson’s disease
Qin, J., Wu, M., Yu, S., Gao, X., Zhang, J., Dong, X., Ji, J., Zhang, Y., Zhou, L., Zhang, Q., et al. (2015) · Toxicology Letters · doi:10.1016/j.toxlet.2015.08.011 · Cited by 43
Kim, H.-W., Choi, W.-S., Sorscher, N., Park, H. J., Tronche, F., Palmiter, R. D., & Xia, Z. (2015) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2015.05.008 · Cited by 43
Self-citationWilliams, A. C., Hill, L. J., & Ramsden, D. B. (2012) · Current Gerontology and Geriatrics Research · doi:10.1155/2012/302875 · Cited by 43
Toxicity, recovery, and resilience in a 3D dopaminergic neuronal in vitro model exposed to rotenone
Harris, G., Eschment, M., Orozco, S. P., McCaffery, J. M., Maclennan, R., Severín, D., Leist, M., Kleensang, A., Pamies, D., Maertens, A., et al. (2018) · Archives of Toxicology · doi:10.1007/s00204-018-2250-8 · Cited by 43
Wang, S., Jiang, Y. X., Liu, Y., Liu, Q., Sun, H., Mei, M., & Liao, X. (2022) · Molecular Neurobiology · doi:10.1007/s12035-022-02731-8 · Cited by 41
Briceño, A., Muñoz, P., Brito, P., Huenchuguala, S., Segura‐Aguilar, J., & Paris, I. B. (2015) · Neurotoxicity Research · doi:10.1007/s12640-015-9560-x · Cited by 41
Hwang, R., Wiemerslage, L., LaBreck, C. J., Khan, M. H., Kannan, K., Wang, X., Zhu, X., Lee, D., & Fridell, Y.-W. C. (2014) · Neurobiology of Disease · doi:10.1016/j.nbd.2014.05.032 · Cited by 40
JNK inhibition of VMAT2 contributes to rotenone-induced oxidative stress and dopamine neuron death
Choi, W.-S., Kim, H.-W., & Xia, Z. (2014) · Toxicology · doi:10.1016/j.tox.2014.12.005 · Cited by 40
Self-citationPiermarini, E., Cartelli, D., Pastore, A., Tozzi, G., Compagnucci, C., Giorda, E., D’Amico, J., Petrini, S., Bertini, E., Cappelletti, G., et al. (2016) · Human Molecular Genetics · doi:10.1093/hmg/ddw260 · Cited by 39
Novel Targets for Parkinson’s Disease: Addressing Different Therapeutic Paradigms and Conundrums
Rane, P., Sarmah, D., Bhute, S., Kaur, H., Goswami, A., Kalia, K., Borah, A., Dave, K. R., Sharma, N., & Bhattacharya, P. (2018) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.8b00180 · Cited by 37
Vitamin B12 Reduces TDP-43 Toxicity by Alleviating Oxidative Stress and Mitochondrial Dysfunction
Jeon, Y., Kwon, Y., Lee, S., Kim, S., Jo, M., Lee, S., Kim, S. R., Kim, K., & Kim, H. (2021) · Antioxidants · doi:10.3390/antiox11010082 · Cited by 37
Zhang, Q., Zhang, J., Jiang, C., Qin, J., Ke, K., & Ding, F. (2014) · Neuroscience · doi:10.1016/j.neuroscience.2014.04.022 · Cited by 36
Dopamine Metabolism and Reactive Oxygen Species Production
Delcambre, S., Nonnenmacher, Y., & Hiller, K. (2016) · Springer eBooks · doi:10.1007/978-3-319-42139-1_2 · Cited by 36
Wang, X., Li, N., Xiong, N., You, Q., Li, J., Yu, J., Qing, H., Wang, T., Cordell, H. J., Isacson, O., et al. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-9861-y · Cited by 35
Lu, J., Chen, S., Shen, M., He, Q., Zhang, Y., Shi, Y., Ding, F., & Zhang, Q. (2018) · Neuroscience Letters · doi:10.1016/j.neulet.2018.09.031 · Cited by 35
The Potential Role of Voltage‐Dependent Anion Channel in the Treatment of Parkinson’s Disease
He, Y., Wang, W., Yang, T., Thomas, E. R., Dai, R., & Li, X. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/4665530 · Cited by 34
Mitochondrial Complex I, a Possible Sensible Site of cAMP Pathway in Aging
Signorile, A., & Rasmo, D. D. (2023) · Antioxidants · doi:10.3390/antiox12020221 · Cited by 33
Musgrove, R. E., King, A. E., & Dickson, T. C. (2012) · Neurotoxicity Research · doi:10.1007/s12640-012-9352-5 · Cited by 33
Sodium salicylate protects against rotenone-induced Parkinsonism in rats
Madathil, S. K., Karuppagounder, S. S., & Mohanakumar, K. P. (2013) · Synapse · doi:10.1002/syn.21658 · Cited by 32
Bongard, R. D., Yan, K., Hoffmann, R. G., Audi, S. H., Zhang, X., Lindemer, B. J., Townsley, M. I., & Merker, M. P. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.07.040 · Cited by 32
Rizzo, F., Ramirez, A., Compagnucci, C., Salani, S., Melzi, V., Bordoni, A., Fortunato, F., Niceforo, A., Bresolin, N., Comi, G. P., et al. (2017) · Scientific Reports · doi:10.1038/srep46271 · Cited by 32
More, S. V., Kumar, H., Kim, I., Koppula, S., Kim, B.-W., & Choi, D. (2013) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/18715273113129990059 · Cited by 32
Binding of Natural Inhibitors to Respiratory Complex I
Schiller, J., & Zickermann, V. (2022) · Pharmaceuticals · doi:10.3390/ph15091088 · Cited by 31
Ko, J., Park, J. H., Park, Y. S., & Koh, H. C. (2016) · Toxicology Letters · doi:10.1016/j.toxlet.2016.08.016 · Cited by 30
Gopi, M., & Janardhanam, V. A. (2017) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2017.02.005 · Cited by 30
Rasheed, M. Z., Khatoon, R., Talat, F., Alam, M. M., Tabassum, H., & Parvez, S. (2023) · ACS Omega · doi:10.1021/acsomega.2c03992 · Cited by 29
Metadata
- Authors
- Choi, W.-S., Palmiter, R. D., & Xia, Z.
- Affiliations
- Howard Hughes Medical Institute (US)
- Corresponding author
- Xia, Zhengui
- ORCID
- Palmiter, Richard D.
- Venue
- Journal of Cell Biology
- Publisher
- Rockefeller University Press
- Published
- 2011-03-07
- Volume
- 192
- Issue
- 5
- Pages
- 873-882
- ISSN
- 0021-9525 (ISSN-L)
- 1540-8140
- PMC
- PMC3051820
- OpenAlex
- W2126516300
- Cited by
- 183
- References
- 59
- Citations by year
- 2026: 10 · 2025: 8 · 2024: 3 · 2023: 6 · 2022: 9 · 2021: 9 · 2020: 8 · 2019: 10 · 2018: 11 · 2017: 9 · 2016: 12 · 2015: 21 · 2014: 19 · 2013: 16 · 2012: 27
- FWCI
- 13.58
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc-sa
- Locations
- The Journal of Cell Biology (publishedVersion, cc-by-nc-sa)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- Funders
- Howard Hughes Medical Institute
- National Institutes of Health
- National Institute of Mental Health (R01MH095840)
- National Institute of Environmental Health Sciences (P30 ES-07033, ES013696, R01ES012215, ES 012215, R01ES013696, P30ES007033)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (P30HD02274, P30HD002274)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Receptors and Signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Keywords
- Parkinson's disease, mitochondrial complex I, NDUFS4, rotenone, piericidin A, microtubule depolymerization, microtubule dysfunction, substantia nigra pars compacta, reactive oxygen species, NADH accumulation, neurotoxicity
- MeSH terms
- Animals, Cytoplasm, Disease Models, Animal, Dopamine, Microtubules, NAD, Nerve Degeneration, Parkinson Disease, Rotenone, Substantia Nigra, 1-Methyl-4-phenylpyridinium, Reactive Oxygen Species, Electron Transport Complex I, Vesicular Monoamine Transport Proteins, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.